Lokal ileri evre meme kanserli hastalarda, neoadjuvan kemoterapinin VEGF ve KI-67 değişimine etkisi
Tez Türü: Tıpta Uzmanlık
Tezin Yürütüldüğü Kurum: Çukurova Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri, Türkiye
Tez Danışmanı: Mustafa Yalçın Kekeç
Tezin Onay Tarihi: 2013
Tezin Dili: İngilizce
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Desteklendiği Program: Diğer
Özet:
Purpose: The aim of this study is aimed to demonstrate the changes in the tumor diameter and expressions of vascular endothelial growth factor (VEGF), estrogen receptor (ER), progesterone receptor (PR), Ki-67, and Cerb-B2 status after neoadjuvant chemotherapy in the patients with locally advanced breast cancer.
Materials and Methods: Sixty-nine patients who diagnosed with locally advanced breast cancer and treated with were prospectively evaluated. The tumor diameter and VEGF, Ki-67, ER, PR, and Cerb-B2 expressions tested by immunohistochemistry (IHC) were evaluated before and after neoadjuvant chemotherapy.
Results: There was a statistically significant reduction in the tumor diameter and in the expression of VEGF, Ki-67, ER, PR, and Cerb-B2 after neoadjuvant chemotherapy.
Conclusion: The significant reduction in VEGF expression suggests that the tumor angiogenesis and its metastatic ability may be reduced by neoadjuvant chemotherapy. The significant change in the Ki-67 proliferation index may suggest the reduced proliferative activity of malignant cells with neoadjuvant chemotherapy.
Keywords: Breast cancer; neoadjuvant chemotherapy; VEGF; Ki-67; ER; PR; Cerb-B2